In addition, recent studies have proposed that P2X7 receptor activation promotes autophagic flux, thereby improving the outcome of non-alcoholic fatty liver disease (NAFLD) through lipophagy [84]. This evidence concerns the gene P2RX7 and metabolic dysfunction-associated steatotic liver disease.